bpc-157 safety adverse effects human BPC-157: A Prohibited Peptide and an Unapproved Drug Found in Health and Wellness Products Is BPC‑157 a Risk? Safety,

The follow-up pivotal trial (METAOD006 / OPTIONS) enrolled a larger cohort and failed to replicate statistically significant weight loss, which led Metabolic Pharmaceuticals to halt the formal drug development program in 2007

This combination is often further studied with other peptides

Continue Reading...

MHRA Threat to clinics In communication with the MHRA, they also stated: However, we do have concerns about the level of clinical oversight present in IV vitamin therapy and injection services in general and the appropriacy of such services is currently under review. This review, if deciding on stopping treatment of B12 injections by clinics who do comply with the ridiculous rules of the MHRA, would not only negatively impact the companies and individuals who give B12 injections, but also to the people who rely on them to keep functioning both physically and mentally

Hands off: do not pick the peeling skin